Sunidhi Securities is bullish on MM Forgings and has recommended buy rating on the stock with a price target of Rs 100 in its August 19, 2013 research report.
Sunidhi Securities' report on MM Forgings
"MM Forgings derives close to 60 percent of its total revenue from exports primarily catering to the large auto manufacturers in the US and Europe. With the US economy improving over the last few quarters and recession in Eurozone coming to an end, the demand is expected to remain firm going forward. MMFL is one of the largest exporters of quality forgings and the company is well poised for significant growth and can increase its market share, going forward. With the global outlook for the automobile industry improving, and more than 475 components under its portfolio MMFL is expected to get huge growth opportunities."
"The demand for forging is on the upward move as the auto manufacturers continue to expand the capacity to meet the ever increasing demand after the recovery in the domestic and global economy. This apart, MMFL has strong relationships with its customers and has not lost any customer during the slowdown which should enable the company to easily ramp up the utilization rates and record strong top-line growth."
Valuation & Recommendation
"With the global outlook for the automobile industry improving and more than 475 components under its portfolio, MMFL is expected to get huge growth opportunities. At the CMP of Rs 72, the share is trading at a P/E of 3.2x on FY14E and 2.6x on FY15E. We recommend BUY with a target price of Rs 100 in the medium term," says Sunidhi Securities research report.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
To read the full report click here
Set email alert for
ADS BY GOOGLE
video of the day
Don’t try to time market; OMCs, paint cos to benefit: Emkay